Shuo Kang - Search Results

Year	Number of Results
2009	1
2010	1
2011	1
2012	4
2013	4
2014	3
2016	3
2017	1
2018	1
2019	1
2020	2
2021	3
2022	5
2023	6
2024	5

1

[Research Progress in Mechanism of Lipid Nephrotoxicity].

Kang S, Zhang X. Kang S, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2022 Oct;44(5):914-918. doi: 10.3881/j.issn.1000.503X.14243. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2022. PMID: 36325791 Free article. Review. Chinese.

2

R1441C and G2019S LRRK2 knockin mice have distinct striatal molecular, physiological, and behavioral alterations.

Xenias HS, Chen C, Kang S, Cherian S, Situ X, Shanmugasundaram B, Liu G, Scesa G, Savio Chan C, Parisiadou L. Xenias HS, et al. Among authors: kang s. Commun Biol. 2022 Nov 10;5(1):1211. doi: 10.1038/s42003-022-04136-8. Commun Biol. 2022. PMID: 36357506 Free PMC article.

3

Cost-effectiveness of adding durvalumab to first-line chemotherapy for extensive-stage small-cell lung cancer in China.

Liu G, Kang S. Liu G, et al. Among authors: kang s. Expert Rev Pharmacoecon Outcomes Res. 2022 Jan;22(1):85-91. doi: 10.1080/14737167.2021.1888717. Epub 2021 Feb 25. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 33627014

4

Redox cycling without reference electrodes.

Sarkar S, Mathwig K, Kang S, Nieuwenhuis AF, Lemay SG. Sarkar S, et al. Among authors: kang s. Analyst. 2014 Nov 21;139(22):6052-7. doi: 10.1039/c4an01287a. Analyst. 2014. PMID: 25271709 Free PMC article.

5

Pathway-specific dysregulation of striatal excitatory synapses by LRRK2 mutations.

Chen C, Soto G, Dumrongprechachan V, Bannon N, Kang S, Kozorovitskiy Y, Parisiadou L. Chen C, et al. Among authors: kang s. Elife. 2020 Oct 2;9:e58997. doi: 10.7554/eLife.58997. Elife. 2020. PMID: 33006315 Free PMC article.

6

Integrated biodetection in a nanofluidic device.

Rassaei L, Mathwig K, Kang S, Heering HA, Lemay SG. Rassaei L, et al. Among authors: kang s. ACS Nano. 2014 Aug 26;8(8):8278-84. doi: 10.1021/nn502678t. ACS Nano. 2014. PMID: 25105352

7

The Impact of a Graded Maximal Exercise Protocol on Exhaled Volatile Organic Compounds: A Pilot Study.

Heaney LM, Kang S, Turner MA, Lindley MR, Thomas CLP. Heaney LM, et al. Among authors: kang s. Molecules. 2022 Jan 7;27(2):370. doi: 10.3390/molecules27020370. Molecules. 2022. PMID: 35056684 Free PMC article.

8

Response time of nanofluidic electrochemical sensors.

Kang S, Mathwig K, Lemay SG. Kang S, et al. Lab Chip. 2012 Apr 7;12(7):1262-7. doi: 10.1039/c2lc21104a. Epub 2012 Feb 24. Lab Chip. 2012. PMID: 22361835

9

Cost-effectiveness of adding serplulimab to first-line chemotherapy for extensive-stage small-cell lung cancer in China.

Kang S, Liu H. Kang S, et al. Expert Rev Pharmacoecon Outcomes Res. 2023 Nov 7:1-8. doi: 10.1080/14737167.2023.2281606. Online ahead of print. Expert Rev Pharmacoecon Outcomes Res. 2023. PMID: 37936507

10

First-Line Treatments for Extensive-Stage Small-Cell Lung Cancer With Immune Checkpoint Inhibitors Plus Chemotherapy: A Network Meta-Analysis and Cost-Effectiveness Analysis.

Kang S, Wang X, Zhang Y, Zhang B, Shang F, Guo W. Kang S, et al. Front Oncol. 2022 Jan 19;11:740091. doi: 10.3389/fonc.2021.740091. eCollection 2021. Front Oncol. 2022. PMID: 35127468 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

36 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year